These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 19901852)
1. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852 [TBL] [Abstract][Full Text] [Related]
2. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Ohtsuka T; Watanabe K; Kaji M; Naruke T; Suemasu K Eur J Cardiothorac Surg; 2006 Jul; 30(1):160-3. PubMed ID: 16723239 [TBL] [Abstract][Full Text] [Related]
3. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Park JH; Lee KS; Kim JH; Shim YM; Kim J; Choi YS; Yi CA Korean J Radiol; 2009; 10(1):12-20. PubMed ID: 19182498 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of thoracoscopic resection for multifocal bronchioloalveolar carcinoma showing pure ground-glass opacities of 20 mm or less in diameter. Mun M; Kohno T J Thorac Cardiovasc Surg; 2007 Oct; 134(4):877-82. PubMed ID: 17903500 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination. Sawada S; Komori E; Nogami N; Segawa Y; Shinkai T; Yamashita M Lung Cancer; 2009 Aug; 65(2):176-9. PubMed ID: 19135757 [TBL] [Abstract][Full Text] [Related]
6. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience. Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation. Lu CH; Hsiao CH; Chang YC; Lee JM; Shih JY; Wu LA; Yu CJ; Liu HM; Shih TT; Yang PC J Thorac Oncol; 2012 Jan; 7(1):143-50. PubMed ID: 22124475 [TBL] [Abstract][Full Text] [Related]
8. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. Lee HY; Lee KS J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733 [TBL] [Abstract][Full Text] [Related]
9. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Mirtcheva RM; Vazquez M; Yankelevitz DF; Henschke CI Clin Imaging; 2002; 26(2):95-100. PubMed ID: 11852215 [TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230 [TBL] [Abstract][Full Text] [Related]
11. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328 [No Abstract] [Full Text] [Related]
12. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Nakata M; Sawada S; Saeki H; Takashima S; Mogami H; Teramoto N; Eguchi K Ann Thorac Surg; 2003 May; 75(5):1601-5; discussion 1605-6. PubMed ID: 12735586 [TBL] [Abstract][Full Text] [Related]
13. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer. Kim HK; Choi YS; Kim K; Shim YM; Jeong SY; Lee KS; Kwon OJ; Kim J J Thorac Oncol; 2009 Oct; 4(10):1242-6. PubMed ID: 19687762 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187 [TBL] [Abstract][Full Text] [Related]
16. Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter. Yamada S; Kohno T Ann Thorac Surg; 2004 Jun; 77(6):1911-5. PubMed ID: 15172235 [TBL] [Abstract][Full Text] [Related]
17. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081 [TBL] [Abstract][Full Text] [Related]
18. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features? Glynn C; Zakowski MF; Ginsberg MS J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229 [TBL] [Abstract][Full Text] [Related]
19. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Sagawa M; Oizumi H; Suzuki H; Uramoto H; Usuda K; Sakurada A; Chida M; Shiono S; Abe J; Hasumi T; Sato M; Sato N; Shibuya J; Deguchi H; Okada Y Eur J Cardiothorac Surg; 2018 Apr; 53(4):849-856. PubMed ID: 29236995 [TBL] [Abstract][Full Text] [Related]
20. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Kim HY; Shim YM; Lee KS; Han J; Yi CA; Kim YK Radiology; 2007 Oct; 245(1):267-75. PubMed ID: 17885195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]